Replay available

Manorama Industries (NSE:MANORAMA) Q2 2027 Earnings Call

Manorama Industries (NSE:MANORAMA) Q2 2027 earnings call, held 2026-11-13. Watch the replay and read the transcript on 6ix.

Fri, November 13, 2026 at 5:26 AMendedReplay
Manorama Industries (NSE:MANORAMA) Q2 2027 Earnings Call
Company
Manorama Industries Ltd. (NSE:MANORAMA)
Period
Q2 2027 earnings call
Date
Fri, Nov 13, 2026, 5:26 AM ET
Replay
Watch the replay on this page · 1 h 2 min

On 6ix: 6ix.com/event/manorama-industries-limited-manorama-q2-2027-earnings-call

Replay

Transcript

Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.

0:00 Ladies and gentlemen, good day, and welcome to the Manorama Industries Limited Q2 and H1 FY 'twenty seven Earnings Conference Call. As a reminder, all participant lines will be in a listen only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Please note that this conference is being recorded. I now hand the conference over to Mr. Hidar Kanya from Investor Relations team. Thank you, and over to you, sir. Thank you, Sofnari. Good afternoon, everyone. On behalf of Manorama Industries Limited, I welcome you all to the company's Q2 and H1 FY 'twenty seven conference call.

0:52 To discuss the performance of the company and to answer your questions, we have with us the management team comprising of mister Deep Sarath, managing director mister Ashish Sarath, president, strategic planning and business development mister Ashok Jain, director and CFO Ms. Ekta Soni, AVP, Investor Relations and Mr. Deepak Sharma, Company Secretary and Compliance Officer. Before we proceed this call, I would like to draw your attention to the fact that today's discussion may contain forward looking statements that are subject to various risks, uncertainties and other factors, which will be beyond management's control. We kindly request to bear in mind that there might be some uncertainties while interpreting such statements.

1:39 Please note that this conference is being recorded. We would now like to start the session with opening remarks from the management team. Afterwards, we will open the floor for an interactive Q and A session. I would now hand over the conference call to Deep Ji for his opening remarks. Thank you, and over to you, sir. Thank you, Hiran. Good afternoon. This is Ashish Sarra, President, Strategic Planning and Business Development. Good afternoon, everybody, and I wish everyone a warm welcome to the Manorama Industries Q2 and Q1 Financial Year twenty seven Earnings Call. Thank you for joining us and for the trust you have placed us and also thank you for your help and wish you a happy festive times and happy Diwali.

2:30 Before we get to the numbers, I would like to take two minutes to explain the leadership changes we announced recently and more important and important and concrete thinking behind them. Manorama today is a very different company from the one we were a few years ago. Our quarterly revenue is now about INR 400 crores. We serve customers in more than 39 countries with exports at 61% of revenue. We have strengthened our balance sheet and we are about to go for major expansions going forward. Our company at this stage deserves dedicated leadership for each part of the business rather than one team carrying every responsibility.

3:18 This is the purpose of this change. It is not a change of direction. It is a step to give every critical area a clear owner. Mr. Modip Kumar Singh, as Chairman, will lead the Board and keep our focus on governance and risk oversight at this scale. Mr. Deep Sarath, as Managing Director, will run operations and execution, manufacturing supply chain, capacity utilization and delivery of our proposed projects. Mrs. Vineetha Sarab, as President, Business Excellence and Development, will strengthen our processes, operational capabilities and strategic growth initiatives. And as I move into the role of passengers and strategic planning and business development, it lets me give up my full time and energy to what I believe will create the most value over the next decade, our long term strategy, our global partnerships, new growth opportunities and the relationship with customers and suppliers that we have built together over many years.

4:29 I'm putting my time where it matters most for this next phase of growth. I would also like to assure you that our strategies, our values and our culture remain exactly the same. Our customers and suppliers continue to work with the same team. What improves is clarity, speed of decision making and accountability as we move further towards a professionally managed systems driven organization. We see Manorama as a growing company with clear defined roles and clarity of purpose to achieve the best results for our stakeholders.

5:18 I have worked with Deep for many years, and I have complete confidence in him and in the entire leadership team. With that, let me hand over to Deep to take you through his priorities and the business. Deep, over to you. Thank you, Ashish. Afternoon, everyone. This is my first earnings call as a Managing Director. So let me begin with a few words about my journey and where I want to take Manorama from here. I have been part of Manorama for more than two decades. In that time, I have worked closely on building our operations, expanding our capabilities and strengthening our customer relationships. I have seen this business grow from a small specialty FADS processor to a global supplier of specialty FADS and motors.

6:08 And much of what we are today was built on the ground plant by plant, customer by customer, together with our team, our tribal collectors community and our partners. It is an honor to take this responsibility, and I do so with a deep sense of ownership. As a Managing Director, my first priority is to deliver our next phase of growth with discipline. Our plan rests on four pillars: expand capacity scale refining premiumize the mix expand globally. Now to the quarter. We are pleased to report another strong performance. Three things drove this: healthy demand, higher volumes across the portfolio, a strong mix of value added products and disciplined execution, including better use of upgraded fractionation facility.

7:03 Exports were at 61% for H1 revenue, and we now serve customers in more than 39 countries across Asia, Europe, U. S, South America, The Middle East and Africa. Innovation anchors our growth. Our BSIR certified Milkoa Innovation and Research Center works with customers and R and D teams to develop application specific products so that we can move steadily from ingredient processing to specialized solutions. With that, I hand over to our CFO, Mr. Ashok Jain, to take through the financial performance in detail. Ashok, over to you. Thank you, Deep sir, and good afternoon, everyone. I will take you through the consolidated financial performance for quarter two and H1 financial year twenty twenty seven.

7:55 Quarter two financial year twenty twenty seven, revenue for the quarter was INR $4.59 crore, up 41.9% from INR $3.23 crore in quarter two FY 'twenty six. Growth came from strong demand across our product portfolio, higher sales volume and a stronger mix of value added products. EBITDA grew by 34.4% to 118 crore. EBITDA margin was 25.8% in quarter two despite higher inbound freight costs, global macro events, example, routes, etcetera. This is largely external and drive to border logistic environment rather than anything structural in our business. Profit after tax grew 51.8% to 81 crores and profit after tax margin expanded 114 basis points to 17.6%.

8:52 First half FY twenty twenty seven revenue grew by 40.8% to $8.63 crore. EBITDA grew by 38%, INR $2.24 crore with EBITDA margin of 26%. Profit after tax grew 59.2% to INR 159 crore and profit after tax margin expanded two thirteen basis points to 18.5%. The domestic to export revenue mix for half year financial year 2027 was INR 30 nine:sixty 1. Now net inventory and cash flow. On cash flow side, operating cash flow outflow for H1 was $2.52 crore. This is timing effect from inventory, not a reflection of the business. Inventory was INR 1,000 crore as of thirty one September 'twenty six compared with INR $7.28 crore in March.

9:46 The main reason is that our Shia procurement earlier this year, alongside our business procurement of salad and mango seeds. This inventory is raw material and in stock we will convert and save. As we expect to normalize through the second half working capital is funded through our existing banking limits and internal resources. Balance is strengthened. Our balance is significantly stronger than at the start of the year. As of 09/31/2026, Net debt equity was 0.0 compared with 0.3 x at the end of FY twenty six. Cash and cash equivalent and other bank balance stood $4.98 crore. To conclude, we have delivered a strong portfolio growth in H1 with a healthy margin profile and a balance sheet that gives the flexibility to fund our next phase of growth.

10:41 That concludes our opening remarks. We can now open the floor for questions. Thank you. Thank you. We will now begin with the question and answer session. May press star and then 1 on the telephone telephone. If you wish to remove yourself from the question queue, you may press star and 2. Participants are requested to please use handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question is in. A reminder to all, you may press star and 1 to ask a question. We have the first question from the line of Nitin from Bank of India Mutual Fund.

11:35 Please go ahead. Hello, everyone. First of all, congratulation, Deepjee, for the elevation. And I think the team is doing the right thing. As the organization grows, we need to have different responsible candidates for different operations. Very right thing to do. Two questions, sir, and probably third is more bookkeeping. So first is with regard to if I were to see the first half number, raw material cost has gone up almost four eighty bps, while other expenses have come down by almost three sixty bps. Net net, our EBITDA margins have still stayed at the zone where it was last year.

12:24 So is there any change in reporting format or reclassification which has happened because of which raw material has gone up to an extent while other expenses have come down? Or it's just a coincidence? That's the question number one. And the question number two is, keeping in mind the input output ratio that we have shown in past, if I were to take INR1000 crores inventory, which is right now sitting in our books, would it be fair to believe that on rolling basis, rolling twelve month basis, we can do a turnover of annualized INR 1,800 crore with this inventory? And one clarification would be on volume growth, if you can highlight, and the utilization of the plant for the quarter.

13:13 Thank you. Thank you, Nitinji for the questions. So the first question with respect to the raw material cost elevation. So we would like to highlight that the raw material cost elevation is primarily what we see in our gross profit level. That is because of our costing with respect to freight cost due to the macroeconomic events what we are seeing globally with the reset movements and hikes in the prices like fuel and every other cost. So we have seen the transportation cost getting high over the last few months and few quarters. That is the effect of that raw material cost. And there is no any change in the formatting with respect to the reporting of the financials.

14:06 And the second question was third question was on the utilization of the plant. So our plant utilization remains approximately around 85% on the expanded capacity, which we believe currently is operating 47,500 tonnes of capacity on 85% utilization roughly. So ideally, we have seen that the contribution from our value added product has gone up by around 75% to the total sales value of our performance. And one question was with regard to the inventory and if I have to do input output calculation, tolling basis turnover, INR1800 crores is doable with this inventory?

15:00 What we believe, of course, it is not that something we can simply annualize it in, but the unit economics, what we have seen in the past shows that calculation only that we should be blocking that kind of a target with this kind of a venture. Got it. Perfect. Thank you. Thank you. We have the next question from the line of Panay Jain from Ambit Capital. Please go ahead. Firstly, congratulation Deepa on the elevation and congratulations on the great set of numbers. So I just have a few questions. So firstly, Ashok, sir, you highlighted that the increase in inventory is due to early procurement of Shia seeds.

15:55 So is there any particular reason for this early purchase? The second question is that what is the status of the backward integration project in Africa, Burkina Faso? And the third question is that what is the status of our LatAm facility? And when can we expect revenue contribution from it? Thank you. Hi. Thank you for the question. For Burkina Faso projects, yes, we are doing a well progress there also because we already have started and we are in a very we we quarter twenty.

16:49 Have already have a acquired the land very in Burkina Faso as we already have intimated in our last Board meeting, but we are expecting regulatory approvals towards the land, and we believe that we can update you much more in detail, maybe in the coming quarters as well as the CapEx progresses. And for latest Sorry, just a follow-up. Is there any specific time line for it? So we are expecting our projects the time lines towards financial year 2028, which is should be around Q3, Q4 of that particular financial year. So we are expecting that time line for our project. Understood. And the second question, which was towards LatAm, yes, it is also progressing well currently because we are already very much booked with our existing capacity, with our existing customers, shipment schedules are booked, and we are gradually increasing volume from our existing plants to go to the LatAm plant and we work there. So that is happening gradually, and we believe that in the next few quarters, maybe in a year or so, we will see a gradual good ramp up towards the Latin market as well. But for Latin market, the product has to go from Indian plant as well. So currently, we see a very booking capacities.

18:12 We are already fully booked for our capacities, but it should gradually ramp over the two quarters. Understood. And about the inventory, Dave? Sorry. Can you repeat your question, please, for inventory days? Yeah. So question was that, sir, highlighted that it was the increase in inventory days were due to early procurement of Shia seeds. So I just wanted to know, is there any particular reason for this early purchase? So there is no particular reason as such because we started and we see that we were getting material, Shia, Nuts and Butters from the West African region because we have recently incorporated and expanded our footprint in West African market. So as we started, we got to receive our materials, and we started shipping that from Africa.

19:12 So that is in the normal course of the business we have done. So that significantly, you will not see in the Q3, Q4 kind of a thing. So going forward, should we expect the same trend to continue like in first half the Shia procurement would be done and the inventories would be elevated? See, we cannot confirm you that it will be only first half or it will be only second half because it happens in the normal course of the business, not just seasonal in the nature. So we have to buy when it comes. So you can take as of now first half and the second half only. If there is any change like we already have half done in the first half, that always will be reported.

19:58 But we cannot simply say that it will only come in first half or it will only come in second half because it is seasonal in nature. Understood. Okay. That's all from my side. Thank you. Thank you. We have the next question from the line of Dipali from Jefferies. Please go ahead. Hello. Congratulations on good set of numbers. Sir, my first question is regarding the revenue grew approximately 42% year on year. Would you be able to quantify how much was driven by volume growth and how much by realization changes? So the on a value based value by basis, we see that contribution from volume growth has been around 8510%, 15%, we can take a pricing realization benefit on the prices.

20:52 And this 4,500 Mbps debottlenecking, when do we think we'll be able to start commercial production from that plant? That is under planning in Q3 only, but we will update you once we have completed that application, but that is under planning in Q3 only. Okay. What is the amount of capital expenditure that we have completed on both backward and forward integration? So including our work in progress and the amount we already have capitalized, you see we have invested around 75 crores towards our current CapEx, and we expect to invest more in the coming quarters in the second half of the year and in the next fiscal year as well.

21:43 So this amount was almost very similar in the previous conference calls. We have not done any CapEx during this quarter? So no. We... Of course, as we stated that this project is a little complex in nature. So yes, that designing engineer has been is in a very critical position of completion. And we believe very soon we are going to release the we have done some advances as and when required to be better for the machineries. So the largest chunk of the investment you can see maybe in the second half or in the coming fiscal year because what we need to design engineer and then that particular thing happens in the second phase. So that is going on, Karim, telling Frank.

22:28 Okay. One small bookkeeping question. How much is the ForEx in the other income? ForEx gain So in and the other income, INR 15 crore is ForEx gain and around INR 10 INR 10 crores of the interest. INR crores. But the other income is INR 10 crores for the quarter. In total, H1, INR 25 crores is the other income. Out of 15 crores is foreign income and 10 crores is the interest on FDR. Sorry. You're asking. Can you repeat? For H1. H1. You're saying for H1. Okay. For h one, you're saying that for 15 crores has been forex gain and 10 crores have been Interest on FDR. The on FDR.

23:22 All right. Thank you. That's it from my end. Thank you. We have the next question from the line of Manchika Gupta from Tusk Investments. Please go ahead. Hello. Hi. Good afternoon. So my question is around the the cocoa prices and and realization from Manorama. So, you know, you already mentioned that the the realization would have been 10 to 15%. It has been impacted by, you know, the cocoa price correction. Like, are the... That is not impacting our our... The realizations customers are demanding from us. And in past calls, you've mentioned that your contracts are nine to twelve months and they're renewed over a long term basis. So are the recent contracts in new is coming in at lower prices? And how much of the book renew in the next two to three quarters?

24:17 So see, it's an ongoing process of contracts getting booked. So we have always stated, and we'd like to repeat that this is not directly that were related to cocoa prices. It doesn't move as cocoa most because the raw materials are very different, the processes are very different, the technologies are little different when we make cocoa butter or cocoa butter equivalent. But with the recent also renewed contracts, we see that we are getting our gross margin change from these products. So that way, we cannot compare with cocoa butter prices and things. We have seen our prices are in a stable mode currently for this product. So indirect impact? There are indirect impacts, but not there are no direct kind of impact.

25:06 Just a small follow-up. So, basically, the prices that we were getting last year... Last quarter rather, which you indicated, we we are directionally in the same level. There's no impact on our CVE's current pricing. No, that way there is no impact. If we want to compare on a thing, so it's not that everything is bad just because CV prices are falling. So the thing we want to clear is on that there is no linkage that way when one commodity prices moves for copper BP to that of our products of SARCIA and MANORAMA. Okay. Thank you. Thank you. We have the next question from the line of Praveen Jayaraman from Eveners Park Institutional Securities.

26:00 Please go ahead. Am I audible? Yes, you're audible. Yes. Congratulations on a strong set of numbers on the elevation, sir. My question is on raw material cost. We understand that the share procurement has led to an increase in inventories this time. What like, was there any increase in share price which we have procured this time compared to last year? Through share price raw material, of course, because of the freight, it has been increased. So that is already reflecting in our book. So that prices have impacted because of the freight cost, which we are importing from those different agents in West African countries. So ma'am, understanding should be the price increases on freight and not on the Shia assets, Shia seat assets.

26:59 Yes, that's what we are saying that there are freight costs largely, which are which have been impacted. And then, of course, there could be a price inflation impact also, which could be there in five seven percent, which is there for every input cost, which is going the inflation kind of price for every raw material, every input price cost has increased. So that you have to take into consideration. Directionally, what would have been the year on year increase in freight cost, which comes in our raw materials? Yes, it comes in under cost only when we are importing share from Africa. So that is part of that. No, no. My question was what will be the percentage increase in freight cost directionally if we compare on year Percentage to year increase. So that we can calculate internally once with the team, and we can let you know this exact percentage of time mode through our.

28:04 Okay. Thanks. Thanks for that. That's it for me. You. We have the next question from the line of Kashik Mohan from Treenetra Asset Managers. Sir, on the good set of numbers. Sir, I just wanted to understand on one single part. We have raised recently funds. Right? I think that will start working from next year. So our ROCs will be coming from next year. Apart from that, with only from existing business and with our existing factory that we have, what can be the full year kind of top end run rate that we're working on if I do double the first half with the second half is my assumptions right over here. And next year, when it comes to the new factory, which has been coming into life from the backward integration and everything, what kind of volume growth that we are going to see? More than pricing, I just want to know on the volume side.

29:01 Yes, of course. We see the H1 has given us a strong base and the second half also should benefit from the capacity ramp up and the remaining debottlenecking, which needs to be done. So of course, we remain confident of our healthy top line growth for full FY twenty twenty seven as well. And with that relates to the volume growth, we expect our capacities to be commissioning around Q3, Q4 FY twenty twenty eight. So we should be wise enough to expect gradual contribution from FY twenty twenty nine onwards or around Q4 FY 'twenty and onwards from some of the projects and CapEx. And the kind of expansion in our volumes will be on a gradual basis. We believe that our capacities have initially given and started with utilization of around 40%, 50%, which in about two or three years gets into optimum utilization of around 85%, 90%.

30:05 Okay. And how about this... Just because we're having this backward integration from the Africa side of things, sir, or, ma'am, like, what are the cost advantages that we are going to benefit? So we see hardly 2% to 3% in company level or maybe we will get the advantage of this integration. So it's very too early to comment on all the financials part, but it should definitely benefit the company in some or the other form, maybe in the raw material sourcing part also, and it should improve in our financials, reflecting our financials also. So the right percentage is too early to communicate as of today, it should benefit the company in the longer term. Got it. Got it. Got it. Thanks, Mohit.

30:59 Thank you. We have the next question from the line of Tushar Khandilwan from Nexus Equities. Please go ahead. Congratulations on great set of numbers. So my question relates to the mix, which has been improving quarter on quarter. So as of this quarter, we the contribution from CB and Stellant, it is coming due in person. So I understand that number which we are processing, there will be part of Olin and styrene, both of them. And I want to understand the ceiling, up to what amount percentage of revenue can come from SIMP and styrene from India, which we have mixed? We have improved currently. If you see the value contribution from CV and steering has gone to 75% approximately for in the range, which was earlier 6570%, now it's currently 70%, 75%.

31:57 So we believe it should be there. And going forward, the range should be healthy. It should be in the range of 70%, 75% only. Going forward, once this upgrade, then we will update you. Okay. So peak peak range would be up to 75% of the revenue that can come from CV and Strain? As of today, with the current mix, we can say that the current capacity at 75 bank, you can say the comfortable bank for the contribution from CV and Strain. It may go it should be in the range between 70% to 80% that can happen, the ranges. With this existing capacity, we should take this the bank. Okay. Got it. Got it. And regarding the solar and filtration plant, what stage of construction it is currently at?

32:51 It's under planning and engineering stage. A lot of things goes around when you plan for this kind of a project. These are little complex fractionation projects because we run all these white crops and yields are different for different raw materials. So that is in a good state. We will keep you updated when something substantially materialized that we'll keep you updated. Okay. Thank you. Thank you. Ladies and gentlemen, in order to ensure that the management is able to address all the questions from the participants in the question queue, we request you to kindly limit your questions to two per participant.

33:38 If you have a follow-up question, please rejoin the queue again. We have the next question from the line of Akhil Parekh from three sixty one Capital. Please go ahead. Yeah. Hi. Thanks for the opportunity. I hope I'm audible. Yes. You're audible again. Yeah. My first question is on the gross margins. Right? Would you be able to share how much of our COGS includes freight cost, basically? The reason I'm asking is because quarter on quarter and on annual, this is we see huge Sorry to interrupt. Okay your voice was not audible in between.

34:25 Could you please repeat your question? Sorry to interrupt. Akhir, you're not audible. We have lost the connection for the current participant. We will take the next question. The next question is from the line of Nippon Sharma from VLS Finance. Please go ahead. Good. Is my voice clear to your end? Yes. You're audible. Okay. So my first question is regarding the plan capacity utilization. So what sort of capacity utilization do you expect for a financial year '27? Because in the previous phone call, it was mentioned that on the conservative basis, we should be able 80%.

35:14 So would it go to 85%? And what is the expected capacity utilization of the new fractionation capacity that will be that is expected to be commissioned in the third quarter of FY 'twenty eight? For existing capacity, yes, it is around 85 currently for the including the debottlenecking capacity, which we have done last quarter, last to last quarter only. So yes, we can expect 85%, 90% around kind of utilization could be there for our existing setup. And as stated earlier, also for new capacity, it takes about two to three years to get into 85%, 90% kind of utilization, what we already have experienced with our existing facilities and capacities of both the vaccination sites.

36:02 So gradual ramp up will take about two to three years, starting from 40%, 50% kind of utilization once the plant commissions. So that should be around FY 'twenty nine only of utilization should be around 40%, 50% of the new chemics. Another question is, could you provide the revenue as well as EBITDA guidance for the upcoming medium term? We are not giving any numeric guidance, but we have stated that we believe that we should be blocking 85% kind of utilization for our existing capacities, and we expect our debottlenecking capacity also to be completed by end of this financial year.

36:48 So we believe that contribution should be around 85 from our SPOCI plant. So that kind of a guidance directionally, can give it and share with our shareholders. Okay. Okay. Just one small question, if I could squeeze in. Just one small question. Yes, please ask. Yes. So could you provide me the average recognition increase in the FY 'twenty six for your CVE? And is it expected to continue for the upcoming medium term as well? You see, we already have done a meaningful increase. We can say in our product mix, we have started on a very low contribution. Now we are contributing around thirty-thirty 5%. So we have come to about 75% of total value added product mix.

37:39 So we have done and we think that between 70% to 80% should be the contribution from all this value added products. Okay. Thank you very much and best of luck for your future endeavors. You, sir. Thank you. We have the next question from the line of Mahima Gidwani from PhillipCapital PMS. Please go ahead. Thanks for the opportunity. My first question is on demand improvement for CBD and specialty sales. So are we seeing any kind of slowdown or order difficulties talking from global chocolate or cosmetic customers because of the current geopolitical situation, particularly in export market? So no, currently, that's because the product what we are manufacturing currently are short in supply only. So we are not seeing any slowdown with respect to demand for our product portfolio.

38:40 The demands are very healthy. Currently, our capacities are also quite booked for the next kind of period. So we don't see that kind of synergy in our products. And then my second question is on growth. So how much of this current growth is coming from new customers or new product approvals? And how much is from higher uptake by existing customers? If you can give a rough estimate of that. So it's a mix of kind of a both. So there is... We cannot share with you the exact percentage currently that how much is contributed by the new customers or the existing old customers, but we are significantly adding new customers from new geographies as well because once you add customers, you are bound to give them the volumes. So we are building currently building on our capacities as the volume production skills are product portfolio customer base with the existing and new will also increase.

39:56 Sorry. Can you be a little clear? We cannot hear you clearly. So my question is not is is level of the level has only around 84 Sorry to interrupt in between. My my... Your voice is breaking. Could you please use your handset more than speak? Hello. Am I audible now? Yes. You're audible. Please go ahead. My second question is on receivables. Have... Our receivables have increased significantly from March 2026 level. So could you please help us understand the reason behind it is a part of the last fifteen days revenue of September month.

40:44 So already we have received the remittance from the customers. So it is normalized. This is normal course of business. It's a receivable quality contained every thirty days. Thank you. We have the next question from the line of Yogita Rathod from Aditya Villa Capital. Firstly, congratulations on the good set of numbers. So I just wanted to understand the fractionation mix in our overall volumes, how will it be going forward for the future years? Sorry. Fractionation mix?

41:33 Of the overall volume. Our overall volume comes from mostly only from vaccination only like the steering, fractions like steering only. So largely, the parts of the volumes are coming from the fractionation unit only. So like 75,000,000 is contributed from CV and steering, and the best contribution are from the other products like olein refined motors and we buy products like VOCs and all. Okay. And in terms of EBITDA margin, can you give some guidance? See, with the guidance, there is no as such any numeric guidance, but the we have reported good set of margin over the last four to six quarters.

42:31 We see that is going well on the bank of around 25% to 27% currently from the business. But it can see modest movements quarter to quarter depending on lot of macroeconomic reasons as well and business has risk also. So currently, we see that particular brand going well in the weaker market in terms what we are currently reporting. Okay. Thank you. Thank you. We have the next question from the line of from Investment. Please go ahead. Congrats on a good set of numbers. My question is currently, I guess, we have capacity of 47,500 metric tons. So you are saying the new capacities will be added from Q3 of next financial year. So apart from the debottlenecking of around 4,000, 5,000 metric ton per annum, where do you see growth coming from till the new capacities come in FY 'twenty eight?

43:41 Basically, Q3 of this year to next Q3. Yes. There are three headrooms which are there currently. We are yet to utilize the capacities we are yet to do due to bottlenecking for our second unit as well. And we believe that there will be 510% kind of a price benefit as well, which we usually get to see from inflation or for other factors, which will get contributed in our total sales mix. So that's where we see that we have a good headroom for this fiscal year and for the next fiscal year as well. If the company is utilizing their capacity on an optimum basis, that is only 30% for the current and the coming fiscal year. So the way you have shown growth in the first half, can you like with current capacities and like utilization of that capacity is up around 85 and before new capacity is coming in, can you sustain this kind of growth? Or would it be difficult with the current capacities to do so?

44:46 See, we always have been reported a good strong set of numbers. It's not only about quarter to quarter movements or six months or six months kind of a movement with respect to the when you see a business, you see business as a whole kind of a thing. And we believe that we have reported good set of growth over the last few quarters, and we see that good growth is going to come in the coming quarter as well. But we won't be able to quantify in terms of percentage that what kind of a growth that is what we believe that what we have done in the past, we will be continuing to doing so in the near future as well with our existing setup and the coming setup. So if you can just tell in the numbers, like, how much capacities would be added and what would be the number in terms of capacity till the time the next capacity is coming?

45:41 Yes. So we already have disclosed lot of information in our press releases, outcomes and presentations for that. If you can refer those materials and then maybe further we can take your questions offline. Sure. The second question is on the again, margin front. You have I mean, you have currently said that around 25, 27% band is comfortable. But do you think from the when the new capacities come on stream next year and as it gradually as it gradually moves the capacity utilization towards 50%, 60%, 70%, do you think there is still scope for margin improvement from here or like this is the best? See, yes, Viti. See, we are investing in the face manner towards our capacities.

46:31 So there are different capacities that are coming and such things are going in a face manner. So we believe and what we have said that the current band, which is there and we are reporting, reasonable. And any updates or movement in the margin front, we'll keep you updated because there could be modest movements could be there in margins quarter to quarter if we see the business. But that is what company is reporting currently. But in EBITDA margin, we'll look as of now comfortable, but we will keep you updated for any quarter. Yes, please go ahead. Madam, due to lot of macroeconomic impacts also, there could be modest movements could be there. But whatever we are reporting currently is within that bank only, 25 to '27.

47:26 So my question was not for short term. Actually, my question was once you start operating at higher capacities in the new capacities, which will be coming from FY 'twenty eight, So that's what I'm asking because of operating leverage once you start getting in maybe in FY 2930. My question was on that front. Yeah. It should improve definitely. There are so many levers to the the product mix would be changing and the operating leverage you should get, economies of scale benefit you should also get. So that should also gradually improve the levers there are so many there in the coming quarters. So structurally, there is a possibility of improvement in the margin, right, in next two, three years because of all these Yes.

48:12 Gradually, it is best, but after all, it is a business. So yes. Sure. All right. Thank you, ma'am. Thank you. We have the next question from the line of Mayur Pargaria from Script Box Wealth Management Private Limited. Please go ahead. Good afternoon, sir. Am I audible clearly? Yes, you're audible. Yes. So congratulations to the entire management team for a great set of numbers. And also congratulations to Mr. Deep for taking over the new responsibilities and wishing you all the best. We have seen Manorama increasing turnover from INR200 crores few years back to almost run rate of now INR1700 crores, INR1800 crores as we annualize this.

49:07 That's a great jump and so has been the profitability and the balance sheet has been maintained. Wishing that the same structure, same discipline continues and we have full faith on it. So great going to the entire team. With that, I have just one observation and now you can throw some light on that. And second is the question. The first is, earlier our greenfield expansion was 25,000 tonnes. Now we are having a capacity expansion of 75,000 tonnes and now it is geographically spread. Further, it is also about the backward integration and some forward integrations there. Given the complexity of this, I hope that management takes all the due care with respect to financial and other planning processes so that by FY 2028, as guided, we are set for the next strong run as we have continued in the past. So given the complexity and given the size on the scale of expansion, if anything you would like to call out with respect to your experiences early in terms of planning, engineering and anything which you foresee in terms of how you see this expansion compared to the past expansions terms of people, in terms of resources, in

50:39 terms of yes. See, it's kind of a day to day learning. We are learning every day with everything what we are doing. With the first expansion of 15,000 tonnes, which was a total greenfield projects, we successfully started and commissioned that. We had a lot of experience from that plant as well. And then we have gone for the second plant of 25,000 tonnes. So whatever learning experience was there from the first plant, we tried to rectify in the second. Now as a company and business, we have the experience of the two fractionation plants successfully running on a good utilization note as well. So we remain confident on our approaches. We have a good team.

51:25 We have a good bandwidth of people as well. We have recruited a lot of people, nationals and internationals also who can contribute their expertise, knowledge with respect to this key project, which are very complex in nature, which needs a very heavy designing and engineering. So that work is there, and we are currently working as a team to complete all our projects. And we believe and we see that we should be clocking time lines, what we have shared with our shareholders for our projects. But whatever any modification is there or whatever if there are any updates, we will keep on sharing with you with all our stakeholders so that everybody is updated with the current setup. But currently, we are still focused on our priorities with projects going forward.

52:23 Thank you for that. And so the other question I had was, while the CapEx and other things are going on, we also have we had even earlier indicated our CBA opportunity, which we are looking at the part of forward integration into that. By the time the capacities come in place, I hope that the product approvals and the trials and the respective everything else is also in place so that we are ready to move as the capacity comes in by FY 'twenty nine. I hope that part is also would you like to throw some color as we move ahead on that side?

53:11 Thank you. We appreciate the concern also for the upcoming projects. But yes, we are in a process. It is a process which takes time planning work, and we as a team are doing so. And what we can share with you that we are fully focused on our priorities with respect to the projects and whatever projects we are working on, the applications we are working on. But currently, we get the team is doing so. We'll focus on that. Ma'am, anything highlight on I'm sorry to interrupt, Mayur. You may please rejoin the queue for more questions. No. This is the clarity. Okay. Fine. Thank you. Thank you. We will take the next question from Sriniv Mehta from Indra Health. Please go ahead.

54:05 Hi. Am I audible? Yes. You're audible. So there is a capital work in progress that I see here, It is around 27 crores against the capital guidance of $2.25 to $2.50 crores. So how much of this $4.60 crores CapEx that you're doing overall has been ordered? What line commissions first and which month? And how much of FY twenty eight revenue do you expect from this new capacity? We also see some board recommendation modifications in the CapEx plan. Is there something that you want to highlight here? We already have discussed this in our earlier statements also.

54:55 And a lot of things what we are repeatedly saying that we will update you if there are any change and updates. What we already have shared that we have invested around INR 70 crores, 75 crores towards that project, and we see that we are going to invest a good chunk also in the second half of this fiscal year. As for the CapEx timeline also, we have shared that it will be you can take it by 28% to three Q4 as a targeted timeline as of today 40%. Then it should start contributing gradually from '29 onwards. Okay. And I'm I'm again asking probably a question which was in a way repeating, but some indication here would be would be helpful.

55:44 So what is the maximum revenue the existing plants can deliver in FY 'twenty eight? Sir, whatever investments we have done so far, we have seen the asset earnings. Generally, we have received around six times x from the investments with our forward integration. So that kind of directionally guidance, we want to we can share with you. So that's how we're on optimal utilization, we believe around 6x, 7x kind of a 6x, 5x, 6x, 7x kind of a return, we can see from our business. It depends on product mix as well, a lot of things impacts here. Next question is from the line of Aditya Sharma from Shikara Investments.

56:44 I just have one question in terms of inventory. We see a sharp pickup from first from Q4 FY 'twenty six to currently Q2 FY 'twenty seven. While you called it out on seasonality, if I go behind and look at last year, it was slightly flattish or downwards in terms of the inventory in the same period last year. So around INR 500 odd crores is what it was. So I'm just trying to understand what has changed because last year, there was no pickup in terms of inventory during this six month period. So if you could just help us understand, is the mix of inventory changed or the pricing obviously would have increased around 510% as you are highlighting, but what led to this large increase?

57:33 Yes. So last year, inventory you saw was largely because we have done the seasons for SAL and MANORAMA. So last year, 500 odd crores inventory was for that particular raw material and some of the finished goods. This year, half year, what you have seen the inventory into Shihan is also what we have bought earlier this year from the West African regions. So we have expanded our regions and so we started getting our nuts and bolts from there, and we have started procuring. So that impact, which is there for current raw material, it's mostly that we already have aligned our share nut procurement for this fiscal year. And it will get normalized during the end of financial year. So generally, what we have seen during the last quarter of the year, we see a heavy inventory and this time it has we have seen in the six months because of the share that we have got earlier. So it will get normalized in the Q3 and Q4 kind of a number.

58:32 Okay. So Sorry to interrupt, Adasdir. I would request you to please rejoin the queue again for more follow-up. Thank you. We have the next question from the line of Utkash Sumaya from Elko Quantum Solutions. Please go ahead. Hi. This is Utkash from ICO Quantum Solutions. Thank you for the opportunity. I'm sorry to be repetitive, man, but you mentioned that you will likely maintain your historical growth rate of 40 odd percent in the next year. But I still... I mean, I... You did explain once, but I still did not understand the levers you have at hand to maintain this kind of growth. I understand you have 4,500 tons of capacity coming, and you also mentioned your value added products will go up from 75% to higher. And you have one more debottlenecking in another unit coming in. So can you explain a little more about the growth levers you have that will sustain this high 40% growth?

59:43 See, it's not that if I will repeat what we said earlier, we have said that the company has reported good set of growth over the last few quarters, and we see that we are going to report good set of growth in the coming quarter as well. So comparing 40%, 30% or 50% would not be the right thing to do at what when we are saying our growth plan, it is for a longer term vision also. So whatever expansion we are doing today to quarters after the debottlenecking or the expanded capacity. When we talk about growth, we talk about as a whole what we are companies taking now and what we are taking now. So it's like comparing it will be 40%, 3020%. It's not what we are communicating or sharing to our shareholders.

1:00:31 But we remain confident on that plan, which is there with respect to CapEx, product mix, the fundamentals of the business. That remains totally intact. That is the core priority, which is there for the whole team currently. And we believe that that should be the same going forward as well. So we'll keep you updated for any ups and downs, which is there in the business. Thank you. Ladies and gentlemen, due to time constraint, we will take that as the last question. And with that, we conclude the question and answer session. I now hand the conference back to the management for the closing comments. We have delivered a strong first half, and we have a clear leadership structure in place for the next phase.

1:01:22 With our integrated business model, strong sourcing capabilities, a growing value added portfolio, wider global reach and a robust balance sheet, we believe Manorama is well positioned to capture the long term opportunity in CBE and specialty fabs and to create sustainable value for all of our stakeholders. Thank you. Thank you, members of the management. On behalf of Manorama Industries Limited, we conclude this conference. Thank you, everyone, for joining with us today, and you may now disconnect your line.

Follow Manorama Industries Ltd. into a list and get an email when it puts out news.

Latest news releases

Companies on this call

More from Manorama Industries Ltd.